Natriuretic peptides and E-selectin as predictors of acute deterioration in patients with inotrope-dependent heart failure

European Journal of Cardio-thoracic Surgery

Volumn 27, Issue 5, 2005, Pages 899-905

  Potapov, Evgenij V ^a   Hennig, Felix ^a   Wagner, Frank D ^a   Volk, Hans Dieter ^b   Sodian, Ralf ^a   Hausmann, Harald ^a   Lehmkuhl, Hans B ^a   Hetzer, Roland ^a  

^a DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

BNP; Cardiogenic shock; E selectin; Heart failure; Heart transplantation; NT proBNP; Ventricular assist device

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; CARDIOGENIC SHOCK; CLINICAL EXAMINATION; CONTROLLED STUDY; FEMALE; HEART FAILURE; HEMODYNAMIC MONITORING; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DOBUTAMINE; DOPAMINE; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; E-SELECTIN; ENOXIMONE; EPIDEMIOLOGIC METHODS; EPINEPHRINE; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; NATRIURETIC PEPTIDES; NERVE TISSUE PROTEINS; NOREPINEPHRINE; PEPTIDE FRAGMENTS; PROGNOSIS; SHOCK, CARDIOGENIC;

EID: 17844376190     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2005.01.050     Document Type: Article

References (25)

1. P. Jaagosild, N.V. Dawson, C. Thomas, N.S. Wenger, J. Tsevat, W.A. Knaus, R.M. Califf, L. Goldman, H. Vidaillet, and A.F. Connors Jr Outcomes of acute exacerbation of severe congestive heart failure: quality of life, resource use, and survival. SUPPORT Investigators. The study to understand prognosis and preferences for outcomes and risks of treatments Arch Intern Med 158 10 1998 1081 1089
2. G.A. MacGowan, R.L. Kormos, D.M. McNamara, R.J. Alvarez, W.D. Rosenblum, S. Pham, A.M. Feldman, and S. Murali Predicting short-term outcome in severely ill heart failure patients: implications regarding listing for urgent cardiac transplantation and patient selection for temporary ventricular assist device support J Card Fail 4 3 1998 169 175
3. R. Sharma, and S.D. Anker Immune and neurohormonal pathways in chronic heart failure Congest Heart Fail 8 1 2002 23 28 and 48
4. R. Sodian, M. Loebe, C. Schmitt, E.V. Potapov, H. Sinawski, J. Müller, H. Hausmann, H. Zurbrügg, Y. Weng, and R. Hetzer Decreased plasma concentration of brain natriuretic peptide as a potential indicator of cardiac recovery in patients supported by mechanical circulatory systems J Am Coll Cardiol 38 7 2001 1942 1949
5. A. Maisel B-type natriuretic peptide levels: a potential novel 'white count' for congestive heart failure J Card Fail 7 2 2001 183 193
6. R.S. Gardner, F. Ozalp, A.J. Murday, S.D. Robb, and T.A. McDonagh N-terminal pro-brain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure Eur Heart J 24 19 2003 1735 1743
7. M.R. Cowie, P. Jourdain, A. Maisel, U. Dahlstrom, F. Follath, R. Isnard, A. Luchner, T. McDonagh, J. Mair, M. Nieminen, and G. Francis Clinical applications of B-type natriuretic peptide (BNP) testing Eur Heart J 24 19 2003 1710 1718
8. G. Torre-Amione, S. Kapadia, C. Benedict, H. Oral, J.B. Young, and D.L. Mann Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the studies of left ventricular dysfunction (SOLVD) J Am Coll Cardiol 27 5 1996 1201 1206
9. T. Tsutamoto, T. Hisanaga, D. Fukai, A. Wada, Y. Maeda, K. Maeda, and M. Kinoshita Prognostic value of plasma soluble intercellular adhesion molecule-1 and endothelin-1 concentration in patients with chronic congestive heart failure Am J Cardiol 76 11 1995 803 808
10. W.H. Yin, J.W. Chen, H.L. Jen, M.C. Chiang, W.P. Huang, A.N. Feng, S.J. Lin, and M.S. Young The prognostic value of circulating soluble cell adhesion molecules in patients with chronic congestive heart failure Eur J Heart Fail 5 4 2003 507 516
11. D. Hasper, M. Hummel, F.X. Kleber, I. Reindl, and H.D. Volk Systemic inflammation in patients with heart failure Eur Heart J 19 5 1998 761 765
12. R.L. Kormos, T.A. Gasior, A. Kawai, S.M. Pham, S. Murali, B.G. Hattler, and B.P. Griffith Transplant candidate's clinical status rather than right ventricular function defines need for univentricular versus biventricular support J Thorac Cardiovasc Surg 111 4 1996 773 782 discussion 782-3
13. A.S. Maisel, P. Krishnaswamy, R.M. Nowak, J. McCord, J.E. Hollander, P. Duc, T. Omland, A.B. Storrow, W.T. Abraham, A.H. Wu, P. Clopton, P.G. Steg, A. Westheim, C.W. Knudsen, A. Perez, R. Kazanegra, H.C. Herrmann, and P.A. McCullough Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure N Engl J Med 347 3 2002 161 167
14. R. Berger, K. Strecker, M. Huelsmann, P. Moser, B. Frey, A. Bojic, B. Stanek, and R. Pacher Prognostic power of neurohumoral parameters in chronic heart failure depends on clinical stage and observation period J Heart Lung Transplant 22 9 2003 1037 1045
15. J.C. Monge Neurohormonal markers of clinical outcome in cardiovascular disease: is endothelin the best one? J Cardiovasc Pharmacol 32 Suppl. 2 1998 S36 S42
16. M.G. Nicholls, J.G. Lainchbury, A.M. Richards, R.W. Troughton, and T.G. Yandle Brain natriuretic peptide-guided therapy for heart failure Ann Med 33 6 2001 422 427
17. M. Richards Outpatient management of heart failure Heart Fail Rev 8 4 2003 345 348
18. R.W. Troughton, C.M. Frampton, T.G. Yandle, E.A. Espiner, M.G. Nicholls, and A.M. Richards Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations Lancet 355 9210 2000 1126 1130
19. K.D. Aaronson, M.J. Eppinger, D.B. Dyke, S. Wright, and F.D. Pagani Left ventricular assist device therapy improves utilization of donor hearts J Am Coll Cardiol 39 8 2002 1247 1254
20. K.D. Aaronson, J.S. Schwartz, T.M. Chen, K.L. Wong, J.E. Goin, and D.M. Mancini Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation Circulation 95 12 1997 2660 2667
21. M. Packer Is tumor necrosis factor an important neurohormonal mechanism in chronic heart failure? Circulation 92 6 1995 1379 1382
22. B. Levine, J. Kalman, L. Mayer, H.M. Fillit, and M. Packer Elevated circulating levels of tumor necrosis factor in severe chronic heart failure N Engl J Med 323 4 1990 236 241
23. D.P. Dutka, J.S. Elborn, F. Delamere, D.J. Shale, and G.K. Morris Tumour necrosis factor alpha in severe congestive cardiac failure Br Heart J 70 2 1993 141 143
24. A.S. Maisel Nesiritide: a new therapy for the treatment of heart failure Cardiovasc Toxicol 3 1 2003 37 42
25. M.P. Schon, T. Krahn, M. Schon, M.L. Rodriguez, H. Antonicek, J.E. Schultz, R.J. Ludwig, T.M. Zollner, E. Bischoff, K.D. Bremm, M. Schramm, K. Henninger, R. Kaufmann, H.P. Gollnick, C.M. Parker, and W.H. Boehncke Efomycine M, a new specific inhibitor of selectin, impairs leukocyte adhesion and alleviates cutaneous inflammation Nat Med 8 4 2002 366 372